Evidence map›Paper›PMID 27103823›Full record

ArticleOncoTargets and therapy2016

Triterpenoid saponin flaccidoside II from Anemone flaccida triggers apoptosis of NF1-associated malignant peripheral nerve sheath tumors via the MAPK-HO-1 pathway.

Lin-Tao Han, Yin Fang, Yan Cao, Feng-Hua Wu, E Liu, Guo-Yan Mo, Fang Huang

Open access · goldAbstract read
In one paragraph

Article in OncoTargets and therapy, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. The complete chloroplast genome of a medicinal plantMitochondrial DNA. Part B, Resources · 2020
    Article
  2. Article
  3. Acta pharmaceutica Sinica. B · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Lin-Tao HanChina Key Laboratory of TCM Resource and Prescription, Ministry of Education, Wuhan, Hubei, People's Republic of China.
Yin FangChina Key Laboratory of TCM Resource and Prescription, Ministry of Education, Wuhan, Hubei, People's Republic of China.
Yan CaoDepartment of Pharmacy, Hubei University of Chinese Medicine, Wuhan, Hubei, People's Republic of China.
Feng-Hua WuChina Key Laboratory of TCM Resource and Prescription, Ministry of Education, Wuhan, Hubei, People's Republic of China.
E LiuDepartment of Pharmacy, Hubei University of Chinese Medicine, Wuhan, Hubei, People's Republic of China.
Guo-Yan MoDepartment of Pharmacy, Hubei University of Chinese Medicine, Wuhan, Hubei, People's Republic of China.
Fang HuangChina Key Laboratory of TCM Resource and Prescription, Ministry of Education, Wuhan, Hubei, People's Republic of China.
Ministry of Education of the People's Republic of China · CNHubei University of Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Malignant peripheral nerve sheath tumors (MPNSTs) are highly aggressive soft tissue neoplasms that are extremely rare and are frequently associated with neurofibromatosis type 1 patients. MPNSTs are typically fatal, and there is no effective treatment so far. In our previous study, we showed that flaccidoside II, one of the triterpenoid saponins isolated from Anemone flaccida Fr. Schmidt, has antitumor potential by inducing apoptosis. In the present study, we found that flaccidoside II inhibits proliferation and facilitates apoptosis in MPNST cell lines ST88-14 and S462. Furthermore, this study provides a mechanism by which the downregulation of heme oxygenase-1 via extracellular signal-regulated kinase-1/2 and p38 mitogen-activated protein kinase pathways is involved in the apoptotic role of flaccidoside II. This study suggested the potential of flaccidoside II as a novel pharmacotherapeutic approach for MPNSTs.

Indexed as

apoptosisflaccidoside IIHO-1malignant peripheral nerve sheath tumorsMAPK

Identifiers

PMID27103823
PMCPMC4827896
OpenAlexW2333510159

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.